| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $32.4M | +163.0% |
| SG&A Expense | $12.9M | +76.9% |
| Operating Income | -$45.2M | -131.0% |
| Income Tax | $0 | — |
| Net Income | -$42.9M | +57.4% |
| EPS (Basic) | -$1.06 | +78.9% |
| EPS (Diluted) | -$1.06 | +78.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $47.5M | -34.1% |
| Current Assets | $180.3M | -9.2% |
| Total Assets | $196.6M | -14.6% |
| Current Liabilities | $7.8M | +51.8% |
| Total Liabilities | $7.8M | +51.8% |
| Stockholders' Equity | $188.8M | -16.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.2M | -95.7% |
| Investing Cash Flow | $39.2M | +137.6% |
| Financing Cash Flow | $3.9M | -98.1% |